Further, a recent preclinical study found that chronic TRPV4 antagonism effectively ameliorates symptoms of hydrocephalus (cranial expansion and ventriculomegaly) in a genetic model of the disease [55]. This evidence concerns the gene TRPV4 and Hydrocephalus.